 Connection
Kent Westbrook to Carcinoma, Ductal, Breast
This is a "connection" page, showing publications Kent Westbrook has written about Carcinoma, Ductal, Breast.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.233 |
|
|
|
-
Makhoul I, Klimberg VS, Korourian S, Henry-Tillman RS, Siegel ER, Westbrook KC, Hutchins LF. Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer. Am J Clin Oncol. 2015 Feb; 38(1):74-9.
Score: 0.116
-
Kepple J, Henry-Tillman RS, Klimberg VS, Layeeque R, Siegel E, Westbrook K, Korourian S. The receptor expression pattern in ductal carcinoma in situ predicts recurrence. Am J Surg. 2006 Jul; 192(1):68-71.
Score: 0.064
-
Korourian S, Klimberg S, Henry-Tillman R, Lindquist D, Jones M, Eng DC, Helsel JC, Mumtaz H, Westbrook K, Harms S. Assessment of proliferating cell nuclear antigen activity using digital image analysis in breast carcinoma following magnetic resonance-guided interstitial laser photocoagulation. Breast J. 2003 Sep-Oct; 9(5):409-13.
Score: 0.053
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|